MBA
LAW
LANGUAGES

AMICUS THERAPEUTICS INC. FOLD (NASDAQ)

$ 9.23

11/18/2008 24:00

Sponsored by

Change: unch (unch%)
Volume: 16,257

Avg. Volume:	16843
P/E Ratio:	0
EPS (Annual):	-1.64
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	22,550
Institutional Shareholders:	28.63%

Last:	9.23
Change:	unch (unch%)
Prev. Close:	9.23
Open:	9.20
Day's Range:	9.00 - 9.50
52wk Range:	7.75 - 18.00
Market Value:	204,070
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	-38.86%
Total Return Last 3 Years:	-35.38%
Total Return Last 5 Years:	-36.66%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on FOLD

Alert me

Earnings roundup: Hana Biosciences, EchoStar

Among the earnings stories for Tuesday, May 13, from AP Financial News: SOUTH SAN FRANCISCO, Calif. (AP) _ Biotech drug developer Hana Biosciences said Tuesday it posted a slimmer ...READ MORE

May 13, 2008 6:58PM

Keywords: SATS, VSAT, JAZZ, FOLD

Revenue lifts Amicus to smaller 1Q loss

(NEW YORK)Biotechnology company Amicus Therapeutics Inc. on Tuesday reported a smaller first-quarter loss as it began to accept revenue and increased its share count.READ MORE

May 13, 2008 5:05PM

Keywords: FOLD, SHPGY